OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pharmacometabolomics Applied to Personalized Medicine in Urological Cancers
Filipa Amaro, Márcia Carvalho, Maria de Lourdes Bastos, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 295-295
Open Access | Times Cited: 14
Filipa Amaro, Márcia Carvalho, Maria de Lourdes Bastos, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 295-295
Open Access | Times Cited: 14
Showing 14 citing articles:
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
Nicola Antonio di Meo, Francesco Lasorsa, Monica Rutigliano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14360-14360
Open Access | Times Cited: 111
Nicola Antonio di Meo, Francesco Lasorsa, Monica Rutigliano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14360-14360
Open Access | Times Cited: 111
Revolutionizing Blood Collection: Innovations, Applications, and the Potential of Microsampling Technologies for Monitoring Metabolites and Lipids
E Bossi, Elena Limo, Lisa Pagani, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 46-46
Open Access | Times Cited: 13
E Bossi, Elena Limo, Lisa Pagani, et al.
Metabolites (2024) Vol. 14, Iss. 1, pp. 46-46
Open Access | Times Cited: 13
Metabolic vulnerabilities in cancer: A new therapeutic strategy
Mohamed El‐Tanani, Syed Arman Rabbani, Yahia El‐Tanani, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104438-104438
Closed Access | Times Cited: 4
Mohamed El‐Tanani, Syed Arman Rabbani, Yahia El‐Tanani, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104438-104438
Closed Access | Times Cited: 4
Pharmacometabolomics Enables Real-World Drug Metabolism Sciences
Fleur B. Nijdam, Marieke A. J. Hof, Hans Blokzijl, et al.
Metabolites (2025) Vol. 15, Iss. 1, pp. 39-39
Open Access
Fleur B. Nijdam, Marieke A. J. Hof, Hans Blokzijl, et al.
Metabolites (2025) Vol. 15, Iss. 1, pp. 39-39
Open Access
Development and validation of a kinase-related gene signature as a novel diagnostic and prognostic model for prostate cancer
Yaqiang Huang, Haiying Zhu, Zhenguo Liang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 4, pp. 167722-167722
Closed Access
Yaqiang Huang, Haiying Zhu, Zhenguo Liang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 4, pp. 167722-167722
Closed Access
Pharmacometabolomics: An emerging platform for understanding the pathophysiological processes and therapeutic interventions
Chandra Prakash, Patrick Moran, Rohit Mahar
International Journal of Pharmaceutics (2025), pp. 125554-125554
Closed Access
Chandra Prakash, Patrick Moran, Rohit Mahar
International Journal of Pharmaceutics (2025), pp. 125554-125554
Closed Access
Metabolomics and Proteomics in Prostate Cancer Research: Overview, Analytical Techniques, Data Analysis, and Recent Clinical Applications
Fatima M. Al-Daffaie, Sara F. Al-Mudhafar, Aya Alhomsi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5071-5071
Open Access | Times Cited: 3
Fatima M. Al-Daffaie, Sara F. Al-Mudhafar, Aya Alhomsi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5071-5071
Open Access | Times Cited: 3
Review on analytical technologies and applications in metabolomics
Xin Meng, Yan Liu, SHUJUN XU, et al.
Biocell (2024) Vol. 48, Iss. 1, pp. 65-78
Open Access | Times Cited: 1
Xin Meng, Yan Liu, SHUJUN XU, et al.
Biocell (2024) Vol. 48, Iss. 1, pp. 65-78
Open Access | Times Cited: 1
Plasma Cabozantinib Level Measurement in Patients with Renal Cell and Hepatocellular Carcinomas Using a Simple HPLC–UV Method Suitable for Clinical Application
Takeo Yasu, Yoshito Gando, Ryosuke Nishijima, et al.
Current Oncology (2023) Vol. 30, Iss. 5, pp. 4871-4879
Open Access | Times Cited: 3
Takeo Yasu, Yoshito Gando, Ryosuke Nishijima, et al.
Current Oncology (2023) Vol. 30, Iss. 5, pp. 4871-4879
Open Access | Times Cited: 3
Metabolomic Signatures of Treatment Response in Bladder Cancer
Tiago Vieira de Sousa, Paula Guedes de Pinho, Joana Pinto
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17543-17543
Open Access | Times Cited: 3
Tiago Vieira de Sousa, Paula Guedes de Pinho, Joana Pinto
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17543-17543
Open Access | Times Cited: 3
The isoflavone corylin suppresses tumor growth and metastasis in renal cell carcinoma by regulating RAGE transcription
Mengru Yang, Xiaoqing Wu, Na Liu, et al.
Journal of Functional Foods (2024) Vol. 120, pp. 106349-106349
Open Access
Mengru Yang, Xiaoqing Wu, Na Liu, et al.
Journal of Functional Foods (2024) Vol. 120, pp. 106349-106349
Open Access
Metabolic signature biomarkers for predicting the recurrence of urological cancers
Filipa Amaro, Márcia Carvalho, Maria de Lourdes Bastos, et al.
Clinica Chimica Acta (2023) Vol. 549, pp. 117553-117553
Open Access | Times Cited: 1
Filipa Amaro, Márcia Carvalho, Maria de Lourdes Bastos, et al.
Clinica Chimica Acta (2023) Vol. 549, pp. 117553-117553
Open Access | Times Cited: 1
Pharmacometabolomics-Based Translational Biomarkers: How to Navigate the Data Ocean
Vivi Bafiti, Θεοδώρα Κάτσιλα
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 10, pp. 542-551
Closed Access | Times Cited: 2
Vivi Bafiti, Θεοδώρα Κάτσιλα
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 10, pp. 542-551
Closed Access | Times Cited: 2
Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial
Dawei Yang, Min‐Jie Ju, Hao Wang, et al.
BMC Pharmacology and Toxicology (2023) Vol. 24, Iss. 1
Open Access
Dawei Yang, Min‐Jie Ju, Hao Wang, et al.
BMC Pharmacology and Toxicology (2023) Vol. 24, Iss. 1
Open Access
